CHD1Li 6.11
CHD1Li 6.11 is a potent inhibitor of oncogenic CHD1L, acting on the cat-CHD1L recombinant protein (IC50: 3.3 μM) . CHD1Li 6.11 is an orally active antitumour agent that significantly reduces the tumour volume of CRC xenografts generated from isolated quasi-mesenchymal cells (M phenotype) with enhanced tumourigenic properties. These cells have enhanced tumourigenic properties.
Product Specifications
CAS Number
2716890-91-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
472.4
Molecular Formula
C21H22BrN5OS
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
sc-341310A 1 g
(2-amino-6-tert-butyl-4,5,6,7-tetrahydro-1-benzothien-3-yl) (4-methylphenyl) methanone
Ask
View Details 
MBS2143635-01 0.1 mL
Biotin-Linked Monoclonal Antibody to Cluster Of Differentiation 86 (CD86)
Ask
View Details 
MBS2143635-02 0.2 mL
Biotin-Linked Monoclonal Antibody to Cluster Of Differentiation 86 (CD86)
Ask
View Details MBS2143635-03 0.5 mL
Biotin-Linked Monoclonal Antibody to Cluster Of Differentiation 86 (CD86)
Ask
View Details MBS2143635-04 1 mL
Biotin-Linked Monoclonal Antibody to Cluster Of Differentiation 86 (CD86)
Ask
View Details